COX-2 specific inhibitors (e.g., coxibs) preferentially reduce amounts of PGI2, tipping the balance toward thrombosis (Vonkeman 2010)
The FDA's 2003 guidance on pharmacokinetics in patients with impaired hepatic function acknowledges that drugs primarily cleared by non-hepatic mechanisms may not require dedicated hepatic impairment studies [5]
Most cases improve over time due to tachyphylaxis, where the body adapts to the medication's effects
After skeletal muscle scanning using CT, a skeletal muscle sample was obtained from the biceps femoris muscle and stained with antibodies against myosin heavy chain specifically expressed in fast-twitch and slow-twitch muscle fibers [72]
For chronic GI conditions including irritable bowel syndrome, inflammatory bowel disease, gastritis, and peptic ulcers, the peptide may offer unique benefits
On training days, increase that further